Efficacy of 104-week sequential therapy with telbivudine or entecavir in HBeAg-positive chronic hepatitis B patients with suboptimal responses to 24-week therapy with pegylated interferon-α-2a
Luo Xiaodan;,Chen Xiaoping;,Chen Ren;,Chen Xuefu;,Huang Jing;

..............page:241-245

Characteristics of HBV transmission in families with HBsAg-positive fathers and familial clustering of HBV infection
yang zuo ;, jin li ;, he ying li ;, liu jin feng ;, wang jing ;, wang ke ;, ma xiao hua ;, li zuo ;, feng yu ling ;

..............page:246-251

Prognostic analysis of acute-on-chronic liver failure after withdrawal of nucleos(t)ide analogues for antiviral treatment of chronic hepatitis B
Ou Shuhua;,Chen Yongpeng;,Jiang Ronglong;,Peng Jie;

..............page:252-257

Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal
sheng qiu ju ;, ding yang ;, li bai jun ;, bai zuo ;, zhang li ;, han chao ;, fan yao zuo ;, li yan wei ;, zuo xiao guang ;

..............page:258-264

Role of glycogen synthase kinase-3β in development of severe hepatitis liver failure caused by hepatitis B virus
zhang xiang ying ;, ren feng ;, wei lin lin ;, guo zuo zuo ;, zhang li ;, wen zuo ;, xie bang xiang ;, shi hong bo ;, pu zheng fu ;

..............page:265-269

Clinical value of contrast-enhanced ultrasound in evaluating portal hypertension in patients with decompensated liver cirrhosis
Zhuang Yuan;,Ding Hong;,Han Hong;,Mao Feng;,Luo Jianjun;,Chen Shiyao;,Wang Wenping;

..............page:270-274

Sole percutaneous microwave coagulation versus its combination with transcatheter arterial chemoembolization for treatment of primary hepatoma: a comparison study
Zeng Yong;,Guan Yongsong;

..............page:275-278

Establishment and evaluation of a mouse model of nonalcoholic steatohepatitis-related hepatocellular carcinoma
luo yan ;, yang wen jun ;, chen jian yu ;, zhang jing ;, zeng xiao dan ;, zhuang zhen jie ;, zuo shu zuo ;, zhou gang ;, di chun hong ;

..............page:279-284

Role of PI3K/AKT signaling pathway in clonogenicity and tumorigenicity of CD90+ stem-like cells of the hepatocellular carcinoma cell line MHCC-97H
peng yu li ;, peng ning fu ;, xie zhi bo ;, lu shi dong ;, zhong jian hong ;, pang ye bin ;, zhu shao liang ;, you xue mei ;, li le qun ;

..............page:285-290

Effect of polyene phosphatidyl choline on hepatocyte steatosis via PPARα/CPT-1A pathway
Wang Tao;,Chen Dongfeng;

..............page:291-296

Strategies in clinical diagnosis and treatment of steroid-resistant acute rejection after orthotopic liver transplantation
Lu Xinjun;,Chen Yinghua;,Ma Yi;,Zhu Xiaofeng;,He Xiaoshun;

..............page:297-301

Clinical features of drug-induced autoimmune hepatitis and drug-induced liver injury: a comparative analysis
Zhao Suxian;,Zhang Yuguo;,Tan Pufang;,Wang Rongqi;,Nan Yuemin;

..............page:302-306

Efficacy of tenofovir monotherapy or lamivudineadefovir dipivoxil combination therapy in treatment of lamivudine-resistant chronic hepatitis B
Qi Jinghu;,Ju Jinchang;,Xu Lei;,Zhang Nannan;,Chen Bin;

..............page:307-309

Wilson's disease misdiagnosed as "nephritis": a report of one case
Liu Yan;,Peng Zhongtian;,Zhou Bin;

..............page:310-311

Alcoholic liver cirrhosis combined leukemoid reaction: a case report
Zhang Yue;

..............page:312

Research advances in the role of CX3CL1 and its receptor in liver diseases
Zhang Pan;,He Shengsong;,Tong Qiaoxia;

..............page:313-316

Significance of HBsAg quantification in guiding clinical treatment of chronic hepatitis B
Yang Xianghui;,Shi Xiaofeng;

..............page:317-320